How do you balance innovation with global healthcare needs, and what role do you see Celltrion playing in shaping the future of healthcare?

Celltrion is advancing its research and development of biological therapies to drive innovation and meet the needs of both patients and the medical community. Biosimilars offer the same benefits as original biologics while reducing costs and supporting a more sustainable healthcare system. These savings can be reinvested into developing new treatments that address unmet patient needs, creating a virtuous cycle.

Beyond biosimilars, Celltrion is committed to developing new drugs to advance global healthcare further. We aim to build an industry that benefits patients and healthcare providers by offering a more comprehensive range of biologic therapies. Through these efforts, we aim to fulfill our role as a leading biopharmaceutical company, contributing to pharmaceutical innovation and establishing a sustainable healthcare ecosystem that shapes the future of healthcare.

We often talk about the importance of collaboration between pharmaceutical companies and physicians. How do you think this collaboration can be most effectively accomplished?

Physicians gather clinical data on patient care and keep patients informed about the latest developments, present various treatment options, and clearly explain why each treatment is necessary. To support this, pharmaceutical companies should provide educational sessions and guidance to help physicians effectively utilize these treatments in practice.

Collaboration between pharmaceutical companies and healthcare institutions is crucial for fostering a transparent decision-making process. This partnership strengthens trust between physicians and patients, allowing healthcare professionals to better prioritize patient health and well-being.

What advice would you give to young medical professionals interested in the intersection of medicine and business?

For young healthcare professionals pursuing careers at the crossroads of medicine and business, I advise embracing challenges and becoming catalysts for change in healthcare. Don’t let societal expectations or stereotypes hold you back. Define your goals and take proactive steps to achieve them. When I started my business, I traveled to over 40 countries, learning from industry experts, which ultimately helped me become a leader in biopharmaceuticals.
Remember, if you have a vision, focus on your journey, and don’t fear setbacks. True success lies not in avoiding failure but rising each time you face it.

As the cover feature of NexBioHealth’s inaugural issue, what are your wishes and suggestions for this magazine aimed at students and young healthcare professionals?

I hope that NexBioHealth’s inaugural issue serves as a source of inspiration for young professionals passionate about science, medicine, and healthcare. I look forward to seeing the magazine expand its readership beyond Asia and Korea, reaching a diverse audience across the U.S. through collaborations with key opinion leaders, companies, and universities.
As Celltrion continues to grow its presence in the U.S. market, we remain committed to becoming a global leader in monoclonal antibody therapies. I also hope NexBioHealth evolves into a trusted and respected publication for healthcare professionals worldwide, supporting the next generation of medical innovators and leaders.